LAVA Therapeutics N.V.

NasdaqGS:LVTX Stock Report

Market Cap: US$28.4m

LAVA Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:LVTX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
06 Mar 24SellUS$4,843,161Novo Holdings A/SCompany1,878,194US$2.65

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of LVTX?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders202,5880.77%
Institutions1,690,9116.43%
Public Companies1,919,4557.3%
Hedge Funds2,074,3727.89%
VC/PE Firms10,009,00738.1%
General Public10,402,33239.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 60.34% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
20.6%
Gilde Healthcare Partners B.V.
5,421,170US$5.9m0%10.62%
17.5%
Versant Venture Management, LLC
4,587,837US$5.0m0%1.92%
7.89%
Redmile Group, LLC
2,074,372US$2.2m0%0.12%
7.3%
Sanofi
1,919,455US$2.1m0%no data
2.94%
Bruce & Co Inc
771,874US$833.6k0%0.25%
0.6%
Fourton Fund Management Co. Ltd
156,833US$169.4k0%0.06%
0.56%
Sphera Funds Management Ltd
146,457US$158.2k-60.2%0.03%
0.39%
Two Sigma Investments, LP
102,766US$111.0k-8.6%no data
0.39%
Pathway Financial Advisors, LLC
102,500US$110.7k70.8%0.03%
0.33%
Alpha Wave Global, LP
87,397US$94.4k0%0.01%
0.29%
Hans van der Vliet
77,350US$83.5k0%no data
0.25%
Fred Powell
65,000US$70.2k0%no data
0.25%
PNC Financial Services Group Inc., Banking Investments
65,000US$70.2k0%no data
0.2%
Tang Capital Management, LLC
53,101US$57.4k939%no data
0.18%
Susquehanna International Group, LLP, Asset Management Arm
48,205US$52.1k0%no data
0.14%
Morgan Stanley, Investment Banking and Brokerage Investments
36,400US$39.3k133%no data
0.11%
Kapil Dhingra
30,000US$32.4k0%no data
0.1%
Two Sigma Advisers, LP
26,900US$29.1k-15.1%no data
0.073%
Virtu Financial LLC, Asset Management Arm
19,103US$20.6k0%no data
0.065%
Citadel Advisors LLC
17,013US$18.4k-74.3%no data
0.056%
Walleye Capital LLC
14,762US$15.9k-42.5%no data
0.046%
Millennium Management LLC
12,063US$13.0k-54.5%no data
0.045%
Engineers Gate Manager LP
11,890US$12.8k0%no data
0.042%
Geode Capital Management, LLC
11,124US$12.0k0%no data
0.038%
Karen Wilson
10,000US$10.8k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/07 08:14
End of Day Share Price 2025/01/07 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

LAVA Therapeutics N.V. is covered by 6 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yu HeH.C. Wainwright & Co.
Christopher HowertonJefferies LLC
Roger SongJefferies LLC